Skip to main content
TipRanks
Go Ultimate75% OFF

Ascentage Pharma Group International (6855) Income Statement

5 Followers

Ascentage Pharma Group International Income Statement

Last quarter (Q2 2026), Ascentage Pharma Group International's total revenue was ¥298.04M, a decrease of 63.82% from the same quarter last year. In Q2, Ascentage Pharma Group International's net income was ¥-805.42M. See Ascentage Pharma Group International’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 559.26M¥ 980.65M¥ 221.98M¥ 209.71M¥ 27.91M
¥ 427.35M¥ 951.57M¥ 191.44M¥ 187.71M¥ 24.58M
¥ 1.61B¥ 1.33B¥ 1.08B¥ 1.07B¥ 957.75M
Depreciation and Amortization¥ 86.48M¥ 93.17M¥ 93.19M¥ 62.91M¥ 28.33M
¥ -1.09B¥ -285.63M¥ -743.61M¥ -820.49M¥ -904.84M
¥ -1.18B¥ -378.80M¥ -891.99M¥ -883.41M¥ -933.17M
¥ -23.24M¥ -16.45M¥ -40.87M¥ -3.77M¥ 100.92M
¥ -1.20B¥ -395.25M¥ -932.86M¥ -887.17M¥ -832.25M
¥ -1.21B¥ -405.43M¥ -925.64M¥ -882.92M¥ -782.42M
Per Share Metrics
Basic EPS¥ -3.40¥ -1.34¥ -3.28¥ -3.35¥ -3.07
Diluted EPS¥ -3.40¥ -1.34¥ -3.28¥ -3.35¥ -3.07
Weighted Average Shares Outstanding356.13M302.06M282.30M263.67M254.62M
Weighted Average Shares Outstanding (Diluted)356.13M302.06M282.30M263.67M254.62M

Currency in CNY

Ascentage Pharma Group International Earnings and Revenue History

-2.4B-1.2B01.2B-12000 %-8000 %-4000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin